Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011;63(6):827-41.
doi: 10.1080/01635581.2011.594208. Epub 2011 Jul 20.

The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial

Robert L Brunner  1 , Jean Wactawski-Wende, Bette J Caan, Barbara B Cochrane, Rowan T Chlebowski, Margery L S Gass, Elizabeth T Jacobs, Andrea Z LaCroix, Dorothy Lane, Joseph Larson, Karen L Margolis, Amy E Millen, Gloria E Sarto, Mara Z Vitolins, Robert B Wallace
Affiliations
Randomized Controlled Trial

The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial

Robert L Brunner et al. Nutr Cancer. 2011.

Abstract

In the Women's Health Initiative (WHI) trial of calcium plus vitamin D (CaD), we examined the treatment effect on incidence and mortality for all invasive cancers. Postmenopausal women (N = 36,282) were randomized to 1,000 mg of elemental calcium with 400 IU vitamin D3 or placebo. Cox models estimated risk of cancer incidence and mortality. After 7.0 yr, 1,306 invasive cancers were diagnosed in the supplement and 1,333 in the placebo group [hazard ratio (HR) = 0.98; CI = 0.90, 1.05, unweighted P = 0.54]. Mortality did not differ between supplement (315, annualized% = .26) and placebo [(347, 0.28%; P = 0.17; HR = 0.90 (0.77, 1.05)]. Significant treatment interactions on incident cancer were found for family history of cancer, personal total intake of vitamin D, smoking, and WHI dietary trial randomized group. Calcium/vitamin D supplementation did not reduce invasive cancer incidence or mortality. Supplementation lowered cancer risk in the WHI healthy diet trial arm and in women without a first-degree relative with cancer. The interactions are only suggestive given multiple testing considerations. The low vitamin D dose provided, limited adherence, and lack of serum 25(OH)D values should be considered when interpreting these findings.

PubMed Disclaimer

Conflict of interest statement

The remaining authors do not report conflicts of interest.

Figures

FIG. 1
FIG. 1
Annualized overall rate of invasive cancer, according to calcium plus vitamin D (CaD) and/or baseline characteristics by treatment group.
FIG. 1
FIG. 1
Annualized overall rate of invasive cancer, according to calcium plus vitamin D (CaD) and/or baseline characteristics by treatment group.
See this image and copyright information in PMC

References

    1. International Agency for Research on Cancer: Vitamin D and Cancer. IARC Working Group Reports. Vol. 5. International Agency for Research on Cancer; Lyon, France: 2008.
    1. Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354:684–696. - PubMed
    1. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst. 2008;100:1581–1591. - PMC - PubMed
    1. Peters U, Chatterjee N, McGlynn KA, Schoen RE, Church TR, et al. Calcium intake and colorectal adenoma in a U.S. colorectal cancer early detection program. Am J Clin Nutr. 2004;80:1358–65. - PubMed
    1. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss E, et al. Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer—results of a large case-control study. Carcinogenesis. 2008;29:93–99. - PubMed

Publication types

Grants and funding